9 results
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
Chronic Obstructive ... post-bronchodilator FEV1 ... Disease #COPD #diagnosis ... #management #GOLD2022 ... #treatment
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
and Management ... Chronic Management ... Avoid meds that ... ↑ bleeding risk ... #Management #treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Silicosis • Chronic ... malignancy, and chronic ... Inhibitor: • Risk ... #Management #Treatment
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
Induced Muscle Toxicity ... muscle fibers Risk ... Pitavastatin Risk ... increased spontaneous activity ... #management #treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Silicosis • Chronic ... malignancy, and chronic ... Inhibitor: • Risk ... #Management #Treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
respiratory distress syndrome ... • Chronic toxicity ... (e.g., chronic ... #Pulmonary #diagnosis ... #management #Toxicology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Risk factors 3. ... Medication/Drug toxicity ... epilepticus Treatment ... underlying cause • Treatment ... #diagnosis #management
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Reconstitution Inflammatory Syndrome ... Drug reaction/ART toxicity ... • Persistently active ... #Inflammatory #Syndrome ... #Management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk ... Malignancy Risk ... Adenocarcinoma Treatment ... muscarinic agonists • Active ... #Management